MENU
VYNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
VYNE Therapeutics (VYNE) Ownership - Who owns VYNE Therapeutics?
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
685 Route 202/206 North
Phone
+1 800 775-7936
Employees
10
Web
https://www.vynetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.29M
P/E Ratio
0.71
Total Cash
61.52M
Projected Growth
N/A
Total Debt
99K
Revenue
501K
Risk (Beta)
2.24
Dividend Yield
N/A
Total Cash/Share
4.04
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
VYNE
Capitalization
28.3M
P/E Ratio
0.71
Risk (Beta)
2.24
Dividend Yield
N/A
Total Cash
61.5M
Total Cash/Share
4.04
Total Debt
99K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
501K
ROE
N/A
Book Value
52.1M
P/B Ratio
0.54
Cash Flow
N/A
Earnings
-0.93
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
4.35
Current Revenue Per Employee
6461.54
Dividends Per Share - Security
N/A
EBITDA
-43.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
60.60
Revenue To Assets
-48.40
Shares Held By Institutions
24.4M
Shares Outstanding - Current
15.2M
Total Liabilities
14.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-44.776
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in development and commercialization of serlopitant products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
685 Route 202/206 North
Phone
+1 800 775-7936
Employees
10
Web
https://www.vynetherapeutics.com